Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18964
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBarr, Elizabeth L M-
dc.contributor.authorBarzi, Federica-
dc.contributor.authorHughes, Jaquelyne T-
dc.contributor.authorJerums, George-
dc.contributor.authorO'Dea, Kerin-
dc.contributor.authorBrown, Alex Dh-
dc.contributor.authorEkinci, Elif I-
dc.contributor.authorJones, Graham R D-
dc.contributor.authorLawton, Paul D-
dc.contributor.authorSinha, Ashim-
dc.contributor.authorMacIsaac, Richard J-
dc.contributor.authorCass, Alan-
dc.contributor.authorMaple-Brown, Louise J-
dc.date.accessioned2018-09-12T23:57:42Z-
dc.date.available2018-09-12T23:57:42Z-
dc.date.issued2018-07-
dc.identifier.citationNephrology 2018; 23(7): 682-689-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18964-
dc.description.abstractWe assessed associations between cardiometabolic risk factors and estimated glomerular filtration rate (eGFR) decline according to baseline albuminuria to identify potential treatment targets in Indigenous Australians. The eGFR Follow-up Study is a longitudinal cohort of 520 Indigenous Australians. Linear regression was used to estimate associations between baseline cardiometabolic risk factors and annual Chronic Kidney Disease Epidemiology Collaboration eGFR change (mL/min per 1.73m2 /year), among those classified with baseline normoalbuminuria (urine albumin-to-creatinine ratio (uACR) <3 mg/mmol; n = 297), microalbuminuria (uACR 3-30 mg/mmol; n = 114) and macroalbuminuria (uACR ≥30 mg/mmol; n = 109). After a median of 3 years follow-up, progressive declines of the age- and sex-adjusted mean eGFR were observed across albuminuria categories (-2.0 [-2.6 to -1.4], -2.5 [-3.7 to -1.3] and -6.3 [-7.8 to -4.9] mL/min per 1.72m2 /year). Although a borderline association was observed between greater baseline haemoglobin A1c and eGFR decline in those with macroalbuminuria (P = 0.059), relationships were not significant in those with microalbuminuria (P = 0.187) or normoalbuminuria (P = 0.23). Greater baseline blood pressure, C-reactive protein, waist-to-hip ratio and lower high-density lipoprotein cholesterol showed non-significant trends with greater eGFR decline in the presence of albuminuria. Over a 3 year period, marked eGFR decline was observed with greater baseline albuminuria. Cardiometabolic risk factors were not strong predictors for eGFR decline in Indigenous Australians without albuminuria. Longer follow-up may elucidate the role of these predictors and other mechanisms in chronic kidney disease progression in this population.-
dc.language.isoeng-
dc.subjectIndigenous-
dc.subjectalbuminuria-
dc.subjectchronic kidney disease (CKD)-
dc.subjectdiabetes mellitus-
dc.subjecthaemoglobin A1c-
dc.subjectRisk Factors-
dc.titleContribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.-
dc.typeJournal Article-
dc.identifier.journaltitleNephrology-
dc.identifier.affiliationMenzies School of Health Research, Darwin, North Territory, Australiaen
dc.identifier.affiliationDiabetes and Endocrinology, Cairns Base Hospital, Cairns, Australiaen
dc.identifier.affiliationNutrition and Population Health, University of South Australia, Adelaide, South Australia, Australiaen
dc.identifier.affiliationBaker Heart and Diabetes Institute, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Royal Darwin Hospital, Darwin, North Territory, Australiaen
dc.identifier.affiliationSansom Institute Health Research, University of South Australia, Adelaide, South Australia, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of New South Wales, Sydney, Australiaen
dc.identifier.affiliationSt Vincent's Hospital, Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSydPath, St Vincent's Hospital, Sydney, New South Wales, Australiaen
dc.identifier.affiliationSouth Australian Health and Medical Research Institute, Adelaide, South Australia, Australiaen
dc.identifier.affiliationDepartment of Endocrinology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1111/nep.13073-
dc.identifier.orcid0000-0001-8058-6977en
dc.identifier.orcid0000-0003-4284-1716-
dc.identifier.orcid0000-0003-2372-395Xen
dc.identifier.orcid0000-0002-1867-4156-
dc.identifier.orcid0000-0003-2112-3918-
dc.identifier.orcid0000-0002-5754-4821-
dc.identifier.pubmedid28503768-
dc.type.austinJournal Article-
local.name.researcherEkinci, Elif I
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Jun 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.